HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Yan Selected Research

Double Outlet Right Ventricle

9/2010Midterm results of arterial switch operation in older patients with severe pulmonary hypertension.
7/2010Safety and efficacy of arterial switch operation in previously inoperable patients.
4/2009[Results of surgical treatment of 1,387 infants under 6 months of age with congenital heart disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Yan Research Topics

Disease

225Neoplasms (Cancer)
03/2022 - 12/2002
55Neoplasm Metastasis (Metastasis)
12/2022 - 05/2005
54Inflammation (Inflammations)
11/2022 - 09/2005
48Infections
11/2022 - 10/2004
27Breast Neoplasms (Breast Cancer)
03/2022 - 11/2006
27Lung Neoplasms (Lung Cancer)
01/2022 - 12/2006
23Hepatocellular Carcinoma (Hepatoma)
02/2022 - 05/2005
22Wounds and Injuries (Trauma)
12/2022 - 02/2007
18Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 06/2009
18Prostatic Neoplasms (Prostate Cancer)
02/2020 - 09/2003
15Carcinogenesis
01/2022 - 04/2003
15Stomach Neoplasms (Stomach Cancer)
11/2021 - 04/2003
14Lymphatic Metastasis
12/2021 - 07/2012
13Body Weight (Weight, Body)
07/2022 - 03/2003
13Urinary Bladder Neoplasms (Bladder Cancer)
11/2021 - 04/2014
13Carcinoma (Carcinomatosis)
12/2017 - 05/2006
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2007
12Sepsis (Septicemia)
01/2021 - 07/2012
11Rectal Neoplasms (Rectal Cancer)
12/2022 - 11/2015
10Necrosis
05/2022 - 06/2010
10Hypoxia (Hypoxemia)
01/2022 - 05/2004
10Glioma (Gliomas)
01/2022 - 08/2015
10Fibrosis (Cirrhosis)
05/2021 - 06/2008
9Disease Progression
01/2022 - 10/2011
9Colonic Neoplasms (Colon Cancer)
12/2021 - 06/2010
9Ventricular Heart Septal Defects (Ventricular Septal Defect)
04/2021 - 04/2009
9Schizophrenia (Dementia Praecox)
01/2020 - 09/2008
9Alzheimer Disease (Alzheimer's Disease)
01/2020 - 04/2013
8Liver Neoplasms (Liver Cancer)
02/2022 - 04/2009
8Colitis
01/2022 - 03/2014
8Pain (Aches)
01/2019 - 01/2006
7Pneumonia (Pneumonitis)
02/2022 - 01/2012
7Neuroinflammatory Diseases
01/2022 - 11/2015
7Adenocarcinoma
01/2022 - 09/2009
7Insulin Resistance
01/2022 - 12/2013
7Hemorrhage
07/2021 - 12/2002
7Congenital Heart Defects (Congenital Heart Defect)
01/2021 - 01/2006
6Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022 - 10/2011
6COVID-19
03/2022 - 01/2020
6Melanoma (Melanoma, Malignant)
10/2020 - 01/2011
6Pulmonary Hypertension
07/2019 - 03/2003
5Burns
05/2022 - 08/2004
5Brain Edema (Cerebral Edema)
01/2022 - 12/2019

Drug/Important Bio-Agent (IBA)

59Proteins (Proteins, Gene)FDA Link
03/2022 - 08/2002
42CytokinesIBA
01/2022 - 01/2006
31Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2013
29Pharmaceutical PreparationsIBA
05/2022 - 08/2005
25Biological ProductsIBA
01/2022 - 09/2005
24Messenger RNA (mRNA)IBA
01/2022 - 05/2004
22MicroRNAs (MicroRNA)IBA
02/2022 - 09/2010
17CollagenIBA
07/2022 - 01/2012
17Monoclonal AntibodiesIBA
01/2022 - 12/2003
14GlucansIBA
01/2022 - 07/2004
14AntigensIBA
11/2021 - 12/2003
13Complement System Proteins (Complement)IBA
01/2022 - 07/2004
12Therapeutic UsesIBA
01/2021 - 07/2008
12beta-GlucansIBA
11/2010 - 12/2003
11LigandsIBA
01/2022 - 11/2006
11Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2011
10Indicators and Reagents (Reagents)IBA
01/2022 - 07/2012
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 10/2007
9Antiviral Agents (Antivirals)IBA
03/2022 - 02/2012
9LipidsIBA
02/2022 - 03/2010
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021 - 05/2014
9Transcription Factors (Transcription Factor)IBA
10/2021 - 03/2011
9DNA (Deoxyribonucleic Acid)IBA
02/2021 - 04/2003
9Interleukin-6 (Interleukin 6)IBA
01/2021 - 05/2012
8Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 11/2015
8Long Noncoding RNAIBA
01/2022 - 08/2014
8CarbonIBA
01/2022 - 05/2014
8Interleukin-17 (Interleukin 17)IBA
01/2022 - 10/2011
8Hormones (Hormone)IBA
12/2021 - 04/2006
8Eosine Yellowish-(YS) (Eosin)IBA
02/2021 - 05/2011
8Hematoxylin (Haematoxylon)IBA
02/2021 - 05/2011
8InterleukinsIBA
01/2021 - 12/2014
7CadmiumIBA
05/2022 - 06/2017
7Interleukin-10 (Interleukin 10)IBA
01/2022 - 05/2012
7Triglycerides (Triacylglycerol)IBA
01/2022 - 04/2003
7AntibodiesIBA
08/2021 - 12/2003
7Small Interfering RNA (siRNA)IBA
01/2021 - 09/2005
7Complement Receptors (Complement Receptor)IBA
11/2010 - 12/2003
6VimentinIBA
03/2022 - 01/2016
6Histones (Histone)IBA
11/2021 - 12/2013
6Phosphotransferases (Kinase)IBA
01/2021 - 09/2008
6GemcitabineFDA Link
01/2020 - 08/2009
6Polysaccharides (Glycans)IBA
07/2017 - 09/2005
6EnzymesIBA
11/2015 - 09/2011
6Complement C3b (C3bi)IBA
06/2013 - 12/2003
5Toll-Like Receptors (Toll-Like Receptor)IBA
03/2022 - 09/2011
5Cadherins (E-Cadherin)IBA
03/2022 - 01/2012
5Cadmium Chloride (Cadmium Dichloride)IBA
02/2022 - 06/2017

Therapy/Procedure

79Therapeutics
03/2022 - 08/2006
30Drug Therapy (Chemotherapy)
01/2022 - 05/2005
28Immunotherapy
03/2022 - 06/2005
11Arterial Switch Operation
04/2021 - 03/2003
9Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2020 - 11/2009
7Neoadjuvant Therapy
07/2022 - 11/2015
6Ligation
07/2018 - 08/2006
6Intraperitoneal Injections
06/2017 - 08/2005
5Hepatectomy
02/2022 - 02/2015